Hensoldt's 77% Order Surge Outruns Sales Growth as Analysts Split on the Stock
Published on 11/09/2026 at 12:50 | Editorial boerse-global.de
Hensoldt's nine-month report card for 2026 landed with a force that few defence names could match this week: order intake of €3,564 million, up 76.7% year on year. Yet the market's response was anything but uniform. The shares added 2.5% in one session, then gave back 3.8% to close at €77.78 on Friday as a global selloff in AI and semiconductor names spilled over into German equities and weighed on the DAX, according to Tagesschau.
The gap between those two moves says as much about the operating story as about the trading tape. Revenue for the same nine-month stretch reached €1,863 million, a gain of 21.3% — brisk, but less than a third of the pace set by new orders. Adjusted EBITDA came in at €281 million, up 33.0%, meaning profitability expanded faster than the top line. That combination — orders compounding far ahead of sales, and earnings compounding faster still — is the core of the bull case.
A Backlog Built for Years, Not Quarters
The order book stood at €10.4 billion, a figure that gives the company unusual visibility for its size. Management also guided the book-to-bill ratio to the upper end of its prior range of roughly 1.5x to 2.0x, a signal that the demand pipeline is not thinning as the year progresses.
On Thursday Hensoldt raised its full-year 2026 outlook, pointing to around €2,800 million in revenue and an adjusted EBITDA margin of about 19.0%. The upgrade raises the bar as much as it raises hopes: delivering on it is now the test that matters.
Should investors sell immediately? Or is it worth buying Hensoldt?
Two Houses, Two Verdicts
Analyst reaction split along a narrow band of price targets but a wider band of conviction. JPMorgan kept Hensoldt at "Neutral" on Thursday with a €100.0 target. Jefferies reaffirmed its "Buy" rating the same day, with a €98 target, as analyst Ben Brown flagged revenue and adjusted EBITDA that had come in above consensus estimates. Deutsche Bank Research weighed in on Friday, maintaining its buy recommendation and a €105 target.
Neither JPMorgan nor Jefferies changed its stance — no upgrades, no downgrades, just confirmation of prior views. The clustering of targets between €98 and €105, against a Friday close of €77.78, suggests the debate is less about where the stock should trade than about how quickly the order book converts into profit.
The Rheinmetall Overhang
Hensoldt's Thursday session had already been rough before the broader market turned. According to dpa-AFX, the stock was dragged down by a fresh guidance cut from Rheinmetall, the sector heavyweight whose warnings tend to ripple across German defence names regardless of individual fundamentals. Good nine-month figures and a raised forecast were not enough to insulate the shares from that pull.
Hensoldt at a turning point? This analysis reveals what investors need to know now.
What comes next has a date attached: a capital markets day in London, where management will have a fresh audience for the conversion story. Between now and then, the metrics that matter are the ones already on the table — whether the €10.4 billion backlog turns into revenue at the pace the guidance implies, and whether margins hold at the roughly 19.0% level the company has staked out. The orders have made the case for growth; the earnings line now has to keep making the case for quality.
Ad
Hensoldt Stock: New Analysis - 9 November
Fresh Hensoldt information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
